Resalis Therapeutics, which received investment from Italian Angels for Growth (IAG) in March, has announced a strategic equity investment from Sanofi. 

Scottish bio-tech Biotangents has completed a £2.3 million investment round led by Eos and British Business Investments through their Regional Angels Programme, and existing investors and Kelvin Capital and Scottish Enterprise.

Animal Health Angels, a group of veterinary and animal health professionals committed to advancing innovation in the animal health industry, has invested in SageTech Medical as part of an ambitious £650,000 seed round led by EMV Capital.

This investment supports SageTech Medical's pioneering work in developing sustainable solutions for anaesthetic gas capture and recycling-a breakthrough with implications for both human and animal healthcare.

Newcells Biotech - whose laboratory models help speed up drug development and reduce reliance on animal testing - has raised a further £1.2m from existing investors Mercia Ventures, Northstar Ventures and North East Finance.

Northern Gritstone has led a £4 million seed investment in Sheffield University spinout Exciting Instruments alongside co-investors Empirical Ventures, NPIF II - Praetura Equity Finance, and serial entrepreneurs Stan Boland and Jonathan Millner.

Chiron Health AI, a health-tech startup which provides a breakthrough model in chronic disease management, has announced the successful completion of its pre-seed funding round, led by SFC Capital. The funding will enable Chiron Health AI to accelerate the launch of its fully integrated B2B product for healthcare payers, providers and pharma, and to develop a new data-driven self-care pathway designed to sit alongside medical care.

Little Journey, the healthtech company transforming the delivery of paediatric care through personalised psychological support, has raised £6m in Series A funding round. Mercia Ventures invested alongside the Northern Powerhouse Investment Fund I (NPIF I), Par Equity, Octopus Ventures, Calm/Storm Ventures, and angel investors.

MintNeuro, a pioneer of scalable, low-power semiconductor technology for minimally-invasive neural implant applications, has raised £1 million in a funding round led by Empirical Ventures. Additional investment came from Parkwalk Advisors (through the Imperial College Enterprise Fund), Imperial College London, Plug & Play, Excellis Holding, and several prominent angel investors.

Research Grid, the AI startup that helps medical research institutions automate back-office admin for clinical trials, has raised a $6.5m seed round. The company will use the new funding to double down on its mission of making clinical trials faster and more successful.

LaennecAI, a pioneering medical AI company based in Cardiff,has announced the successful completion of its pre-seed funding round. The company has secured investment from SFC Capital and OVC Ventures, along with grant funding from the Welsh Government, Innovate UK, and the National Institute for Health Research (NIHR). This combined support will accelerate the development of LaennecAI's software that turns every smartphone into an advanced digital stethoscope, aiming to bring healthcare closer to patients and usher in a new era of self-care

ReneuralTM has raised £200K in a pre-seed funding round led by SFC Capital, with an additional £275K in support from Innovate UK.  Reneural Technologies Limited, formerly known as CardioCrown, is addressing the critical gap in effective and continuous rehabilitation for stroke survivors with its innovative approach to enhance patient outcomes, reduce clinician burnout, and lowes healthcare costs. The company facilitates early discharge from hospitals, improves patient engagement and compliance, while enabling efficient remote care.

Scalpel AI, a London-based medtech transforming the management of surgical tools and implants using computer vision, has raised £3.8m ($4.8m) in a funding round led by Mercia Ventures, with participation from Tensor Ventures and private investors.  The investment will enable Scalpel AI to scale its global operations and roll out its technology with major players in the healthcare supply chain, including sterile services, hospitals, and prominent third-party logistics (3PL) services such as GlobalMed Logistix (GMLx).